Louisiana State Employees Retirement System Sells 400 Shares of Masimo Co. (NASDAQ:MASI)

Louisiana State Employees Retirement System cut its stake in Masimo Co. (NASDAQ:MASI) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,200 shares of the medical equipment provider’s stock after selling 400 shares during the period. Louisiana State Employees Retirement System’s holdings in Masimo were worth $1,627,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. NBC Securities Inc. raised its position in Masimo by 47.1% during the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 73 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Masimo by 75.0% during the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 111 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Masimo by 133.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 200 shares during the last quarter. Lazard Asset Management LLC boosted its stake in Masimo by 5,730.0% in the first quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 573 shares in the last quarter. Finally, HHM Wealth Advisors LLC grew its position in Masimo by 25.0% in the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock valued at $79,000 after acquiring an additional 125 shares during the last quarter. Institutional investors own 85.96% of the company’s stock.

Masimo Stock Performance

Shares of MASI stock opened at $144.01 on Friday. Masimo Co. has a one year low of $75.36 and a one year high of $153.93. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. The business’s 50 day simple moving average is $128.51 and its 200 day simple moving average is $125.14. The stock has a market capitalization of $7.66 billion, a PE ratio of 97.97 and a beta of 0.99.

Masimo (NASDAQ:MASI) last released its earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, topping the consensus estimate of $0.77 by $0.09. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The business had revenue of $496.30 million during the quarter, compared to analysts’ expectations of $493.92 million. During the same quarter last year, the firm posted $0.62 earnings per share. The firm’s revenue was up 9.0% on a year-over-year basis. As a group, research analysts forecast that Masimo Co. will post 3.88 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on MASI. BTIG Research increased their target price on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Piper Sandler reaffirmed an “overweight” rating on shares of Masimo in a research note on Friday, October 18th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Friday, September 20th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $145.33.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.